Mat, Breech Ivy L.
HRN: 14-05-38 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
10/04/2022
10/13/2022
PO
7ml
Q8
Age With Moderate Dehydration T/c Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes